Body mass index and response to antidepressants in depressed research subjects

Journal of Clinical Psychiatry

Volumn 70, Issue 11, 2009, Pages 1609-

  Oskooilar, Nader ^a   Wilcox, Charles S ^a   Tong, My Linh ^a   Grosz, Daniel E ^a  

^a Pharmacology Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; NEUROTRANSMITTER; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

BODY MASS; BODY WEIGHT; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG DOSE TITRATION; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; HAMILTON SCALE; HUMAN; INFLAMMATION; LETTER; MAJOR DEPRESSION; MENTAL DISEASE; MENTAL PATIENT; META ANALYSIS; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MOOD DISORDER; NEUROTRANSMISSION; OBESITY; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOPHARMACOTHERAPY; STRESS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; ANTIDEPRESSIVE AGENTS; BODY MASS INDEX; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; DRUG RESISTANCE; HUMANS; INFLAMMATION; MIDDLE AGED; NEUROTRANSMITTER UPTAKE INHIBITORS; OBESITY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 72849109655     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.09l05226blu     Document Type: Letter

References (11)

1. Simon GE, VonKorff M, Saunders K, et al. Association between obesity and psychiatric disorders in the US adult population. Arch Gen Psychiatry 2006;63(7):824-830 PubMed doi:10.1001/archpsyc.63.7.824
2. Markowitz S, Friedman MA, Arent SM. Understanding the relation between obesity and depression: causal mechanisms and implications for treatment. Clin Psychol Sci Pract. 2008;15(1):1-20. doi:10.1111/j.1468-2850.2008.00106.x
3. Dantzer R, O'Connor JC, Freund GG, et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9(1):46-56. PubMed doi:10.1038/nrn2297 (Pubitemid 350295688)
4. Omoigui S. The interleukin-6 inflammation pathway from cholesterol to aging-role of statins, bisphosphonates and plant polyphenols in aging and age-related diseases. Immun Ageing. 2007;4(1):1-22. PubMed doi:10.1186/1742- 4933-4-1
5. Lydiard RB. Worried sick: antidepressants, stress, and inflammation. J Clin Psychiatry. 2007;68(10):1613-1614. PubMed
6. Rosmond R. Obesity and depression: same disease, different names? Med Hypotheses. 2004;62(6):976-979. PubMed doi:10.1016/j.mehy.2003.12.030
7. Papakostas GI, Petersen T, Iosifescu DV, et al. Obesity among outpatients with major depressive disorder. Int J Neuropharmacol. 2005;8(1):59-63. (Pubitemid 40388814)
8. Sheehan DV, Lecrubier Y, Harneh-Sheehan K, et al. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(suppl 20):22-23. PubMed (Pubitemid 29001829)
9. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62. PubMed doi:10.1136/jnnp.23.1.56
10. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-389. PubMed doi:10.1192/bjp.134.4.382 (Pubitemid 9136500)
11. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, MD: National Institute of Mental Health; 1976:218-222.